Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Yong-Zi Chen"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundCytokines are involved in many inflammatory diseases and thus play an important role in tumor immune regulation. In recent years, researchers have found that breast cancer is not only related to genetic and environmental factors, but also t
Externí odkaz:
https://doaj.org/article/2dbcdab66d2443d6a2467988f48e886b
Publikováno v:
Frontiers in Artificial Intelligence, Vol 5 (2022)
Externí odkaz:
https://doaj.org/article/f3696c4a19554bd89f913f89012ce443
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Objective: To identify CT imaging biomarkers based on radiomic features for predicting brain metastases (BM) in patients with ALK-rearranged non-small cell lung cancer (NSCLC).Methods: NSCLC patients with pathologically confirmed ALK rearrangement fr
Externí odkaz:
https://doaj.org/article/8475c324b4a847f5ad26e01ea3878133
Autor:
Xu Wang MM, Yehui Shi MD, Yongsheng Jia MD, Weipeng Zhao MD, Li Zhang MD, Guiying Bai MM, Yulin Ren MM, Yong-Zi Chen PhD, Zhongsheng Tong MM
Publikováno v:
Technology in Cancer Research & Treatment, Vol 20 (2021)
Objective : This study aimed to investigate the tolerance and pharmacokinetic characteristics of recombinant human endostatin (rh-endostatin) administered as single-dose or multiple-dose infusions in patients with advanced solid tumors. Methods : Thi
Externí odkaz:
https://doaj.org/article/05d6a54ddabb4ee9a0628d134572ce97
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e39195 (2012)
Sumoylation is one of the most essential mechanisms of reversible protein post-translational modifications and is a crucial biochemical process in the regulation of a variety of important biological functions. Sumoylation is also closely involved in
Externí odkaz:
https://doaj.org/article/49ff82a277cf485ca943b2d902555cda
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e22930 (2011)
As one of the most important reversible protein post-translation modifications, ubiquitination has been reported to be involved in lots of biological processes and closely implicated with various diseases. To fully decipher the molecular mechanisms o
Externí odkaz:
https://doaj.org/article/ff96e5d1d0544d5ca0936e5fe74def59
Autor:
Gary K. Koski, Amrita Basu, Payal Grover, Qianxing Mo, Hatem Soliman, Brian J. Czerniecki, Hyo S. Han, Mark I. Greene, Doris Wiener, Colin Snyder, Hongtao Zhang, Yong-Zi Chen, Jose R. Conejo-Garcia, Ricardo Costa, Ganesan Ramamoorthi, Zhongsheng Tong, Krithika Kodumudi, Catherine A. Lee, Shari Pilon-Thomas, Yongsheng Jia
Publikováno v:
Molecular Therapy. 29:1541-1556
HER2 breast cancer (BC) remains a significant problem in patients with locally advanced or metastatic BC. We investigated the relationship between T helper 1 (Th1) immune response and the proteasomal degradation pathway (PDP), in HER2-sensitive and -
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74d37f99016118a06c5cf40f369121ca
https://doi.org/10.1016/j.ymthe.2020.12.037
https://doi.org/10.1016/j.ymthe.2020.12.037
Publikováno v:
Frontiers in genetics. 13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b4fa04cac268cb1be320be75034b3fc0
https://pubmed.ncbi.nlm.nih.gov/35281837
https://pubmed.ncbi.nlm.nih.gov/35281837
Publikováno v:
Brief Bioinform
Lysine crotonylation (Kcr) is a newly discovered type of protein post-translational modification and has been reported to be involved in various pathophysiological processes. High-resolution mass spectrometry is the primary approach for identificatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05c04b105a116a201115d0b677e1786a
https://doi.org/10.1093/bib/bbab146
https://doi.org/10.1093/bib/bbab146
Autor:
Su Zhang, Yong Zi Chen, Xiao Lin Zhu, Xi Hao Zhang, Ti Zhang, Dong Ming Liu, Lu Chen, Man Qing Cao, Zhi Wei Wang, Li Wei Chen, Hua Guo, Luo Yi, Hong Yuan Zhou, Zhen Yu Hou, Yun Long Cui, Ke Yun Zhu, Hui Kai Li, Xiao Ying Gu
Anti-angiogenic drugs (AADs) are currently the main choice for systemic treatment of hepatocellular carcinoma, but treatment-related proteinuria can affect the routine use of AADs, which in turn affects the overall efficacy, its prevention is a clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2981fc0097882eee5a2b047ce5c22db1
https://doi.org/10.21203/rs.3.rs-72739/v2
https://doi.org/10.21203/rs.3.rs-72739/v2
